GlassScriptPhysician profile
Kim M Johnson
NPI 1871614024
$1,473.06
in general payments reported to CMS, 2019-2025
25 companies · $82.45 in 2025
The $82.45 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $156 · 2021: $122 · 2022: $468 · 2023: $234 · 2024: $294 · 2025: $82.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $570 · Education: $40.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $570.42 |
| Education | $40.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $224.05 | 2020-2024 | |
| Astellas Pharma US INC | $170.33 | 2023-2024 | Veozah |
| Aspira Women'S Health INC | $149.94 | 2022 | |
| Coopersurgical, INC. | $115.51 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Exeltis, USA INC. | $93.66 | 2021-2024 | Slynd |
| Millicent US INC | $82.67 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $65.43 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $63.08 | 2021-2022 | |
| Dysis Medical, INC. | $62.89 | 2020 | |
| Myovant Sciences INC. | $58.10 | 2022 | |
| Sumitomo Pharma America, INC. | $54.23 | 2023-2024 | Myfembree |
| Hologic Sales and Service, LLC | $43.79 | 2025 | Myosure Tissue Removal Device, Novasure |
| Evofem Biosciences, INC. | $34.11 | 2021-2022 | |
| Allergan, INC. | $32.34 | 2019-2020 | |
| Pfizer INC. | $29.24 | 2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Springworks Therapeutics, INC. | $28.03 | 2024 | Ogsiveo |
| Exact Sciences Corporation | $22.78 | 2023 | Cologuard Collection Kit |
| Scynexis, INC. | $22.02 | 2022 | |
| Avion Pharmaceuticals | $21.85 | 2022 | |
| Amag Pharmaceuticals, INC. | $18.91 | 2019 | |
| Covidien LP | $18.47 | 2019 | |
| Ferring Pharmaceuticals INC. | $16.55 | 2019 | |
| Smith+Nephew, INC. | $16.18 | 2020 | |
| Agile Therapeutics, INC. | $15.57 | 2024 | Twirla |
| Therapeuticsmd, INC. | $13.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kim Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.